INBX Earnings

Quarterly EPS
$-2.84
Q3 2024
$-3.09
Q4 2024
$-2.80
Q1 2025
$-1.85
Q2 2025
$-2.28
Q3 2025
$-2.11
Q4 2025
$-2.15
Q1 2026
$-2.34
Q2 2026
Latest RevenueN/A
Latest Net Income-36650000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$2.340-36650000-100.0%-26.5%
Q1 2026-$2.150-33441000+23.2%
Q4 2025-$2.110-32834000-100.0%+31.7%
Q3 2025-$2.280-35256000+19.7%
Q2 2025-$1.851.3M-28654000+1,200.0%-101.5%
Q1 2025-$2.800-43311000
Q4 2024-$3.09100.0K-47865000
Q3 2024-$2.840-43864000
Q2 2024$127.10100.0K1.9B
Inhibrx Biosciences (INBX) — Earnings